Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China to Grant India Greater Access to its Pharma Market

publication date: Aug 27, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China agreed to give India greater access to its markets for pharma, agriculture and IT products. India has been upset with China because only $18 billion of products flows from India to China, while $57 billion of China products found its way to India over the past 12 months. Most of India’s trade deficit derives from its relationship with China. For its part, China is fretting about a 21% customs duty – done as a warning to China – that India has levied on China power equipment. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...